Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Pharming Group NV (PHGUF) had Debt to Equity Ratio of 0.51 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$297.20M |
|
$-11.84M |
|
$35.40M |
|
$261.80M |
|
$305.82M |
|
$-8.62M |
|
$0.13M |
|
$-8.49M |
|
$-8.49M |
|
$-11.84M |
|
$-11.84M |
|
$-11.84M |
|
$-11.84M |
|
$-8.62M |
|
$7.45M |
|
671.35M |
|
785.41M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$278.44M |
|
$7.75M |
|
$121.56M |
|
$399.99M |
|
$73.80M |
|
$105.12M |
|
$105.12M |
|
$178.92M |
|
$221.06M |
|
$160.02M |
|
$221.06M |
|
680.31M |
|
| Cash Flow Statement Financials | |
$-1.79M |
|
$31.62M |
|
$-34.41M |
|
$61.74M |
|
$54.94M |
|
$-6.80M |
|
$11.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.77 |
|
-- |
|
-- |
|
0.32 |
|
|
Debt to Equity Ratio |
0.51 |
88.09% |
|
-2.90% |
|
-2.90% |
|
2.51% |
|
-2.86% |
|
-3.98% |
|
$-2.58M |
|
-- |
|
-- |
|
-- |
|
0.74 |
|
0.64 |
|
5.42 |
|
67.33 |
|
-5.36% |
|
-7.40% |
|
-2.96% |
|
-3.63% |
|
$0.32 |
|
$-0.00 |
|
$-0.00 |
|